Breztri Aerosphere (budesonide/formoterol fumarate/glycopyrronium) - AstraZeneca
Trimbow (beclometasone/formoterol/glycopyrrolate) - Chiesi
Airway deposition of two fixed-dose triple combination pMDI drugs at different inhalation flow rates and insertion angles. (PubMed, Eur J Pharm Sci) - Jul 25, 2026 - "The objective of this study was to establish a robust experimental and computational framework for characterizing pressurized metered-dose inhaler (pMDI) plumes and quantifying regional deposition fractions of two triple-combination aerosol drugs, Trimbow® (BDP/GLY/FF) and Trixeo Aerosphere® (BUD/GLY/FF). A slightly upward mouthpiece insertion enhanced lung deposition, whereas a downward orientation reduced it compared to horizontal positioning. These findings underscore the importance of inhalation technique and device orientation in optimizing therapeutic efficacy of pMDI-delivered triple-combination drugs." 
Journal
http://www.ncbi.nlm.nih.gov/pubmed/42497946
 
Alpár Horváth; András Keglevich; Árpád Farkas; Attila Nagy; Balazs Santa; Etelka Nagy; Tamás Kovács
 
Jul 25, 2026
 
Prev Next